Keratoconjunctivitis Sicca: all 797 studies
Page 8 of 8. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Diurnal Variation in Tear OsmolarityCompletedNCT01321424
- Local Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young VolunteersCompletedNCT01278784Phase 1
- The Effect of Ocular Lubricant Eyedrops on Lid Parallel Conjunctival Folds and Other Signs and Symptoms of Dry EyeCompletedNCT01268735Phase 4
- Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry EyeCompletedNCT01257607Phase 2
- The Pathogenesis of Idiopathic Dry EyesCompletedNCT01254201
- Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye DiseaseCompletedNCT01239069Phase 2
- A Study Of Tasocitinib In Dry Eye SubjectsWithdrawnNCT01226680Phase 2
- An Open-Label, Single-Center Study Evaluating the Effect of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in Patients Diagnosed With Dry EyeCompletedNCT01223040Not applicable
- Omega-3 Fatty Acid Supplements and Dry EyeTerminatedNCT01213342Not applicable
- A Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01211951Phase 2
- Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis PatientsCompletedNCT01203540Phase 4
- Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome.CompletedNCT01178242Not applicable
- TearLab Refractive Surgery Dry Eye StudyCompletedNCT01176045
- Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry EyeCompletedNCT01129856Phase 3
- Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye PatientsCompletedNCT01118754Phase 1/2
- Efficacy of Systane Ultra in Post Menopausal Women With Dry EyeCompletedNCT01105910Phase 4
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)CompletedNCT01105624Phase 4
- Acupuncture for Dry EyeCompletedNCT01105221Phase 3
- Study of DE-089 Ophthalmic Solution in Patients With Dry EyeCompletedNCT01101984Not applicable
- Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye SubjectsCompletedNCT01086774Phase 4
- A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular LensCompletedNCT01061268Phase 4
- Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central CorneaCompletedNCT01057147Phase 2
- Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry EyeCompletedNCT01027013Phase 2
- Prospective Health Assessment of Cataract Patients' Ocular SurfaceCompletedNCT01016405
- Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young VolunteersCompletedNCT01015209Phase 1
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye DiseaseCompletedNCT01014078Phase 4
- Clinical Evaluation of the Causes of Contact Lens Related Dry EyeCompletedNCT00995189Not applicable
- CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye SyndromeCompletedNCT00991679
- Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 DaysCompletedNCT00946777Not applicable
- Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®CompletedNCT00893243
- A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry EyeCompletedNCT00893139Phase 2
- Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry EyeCompletedNCT00883649Not applicable
- A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)CompletedNCT00851734Phase 1
- A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye PatientsCompletedNCT00840268Phase 2
- A Natural History Study of Patients With Dry EyeCompletedNCT00833235
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)CompletedNCT00831662Phase 3
- A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) ModelCompletedNCT00814944Phase 2
- Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT00814515Phase 3
- Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye DiseaseCompletedNCT00809003
- Partial Lacrimal Punctual OcclusionCompletedNCT00802399Not applicable
- Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry EyeCompletedNCT00799552Phase 2
- Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency VirusStatus unknownNCT00797030Phase 4
- Efficacy and Safety Study of ATs in Patients With Dry Eye SyndromeCompletedNCT00788229Phase 2
- A Prospective, Randomized, Double-Masked, Single Center, Clinical Comparison of the Use of Systane Ultra in the Management of Dry Eyes in Bilateral EyesCompletedNCT00781092Phase 4
- Autologous Serum Efficacy Study in Patients With Severe Dry EyeCompletedNCT00779987Phase 2
- Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry EyeCompletedNCT00765804Phase 2
- Effects of Sea Buckthorn Oil on Dry EyeCompletedNCT00739713Not applicable
- Lid Margin And Conjunctival Microbial Flora Following Punctum OcclusionCompletedNCT00735865Not applicable
- Evaluate Artificial Tear Efficacy in Moderate to Severe Dry EyeCompletedNCT00724412Phase 4
- Phase 2 Study of KLS-0611 in Patients With Dry Eye SyndromesCompletedNCT00721656Phase 2
- The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye PatientsStatus unknownNCT00718926
- Tear Dynamics After Restasis Treatment in Dry Eye PatientsCompletedNCT00706940
- Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry EyesStatus unknownNCT00704275Phase 4
- A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic SolutionCompletedNCT00680108Phase 2
- A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye DiseaseCompletedNCT00679718Phase 2
- Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).CompletedNCT00620893Phase 4
- Artificial Tears Study in Mild to Moderate Dry Eye PatientsCompletedNCT00607776Phase 2
- Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)CompletedNCT00600288Phase 3
- Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye SyndromeCompletedNCT00599716Phase 3
- Objective Measurements of Prolonged Effects of Restasis on Dry Eye DiseaseCompletedNCT00567177Phase 4
- Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry EyeCompletedNCT00560638Phase 2
- Acupuncture Treatment of Dry EyeCompletedNCT00554879Not applicable
- The Relationship of Residence Time and Visual Effect of Optive and Systane in Dry Eye SubjectsCompletedNCT00553579
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)CompletedNCT00549289Phase 3
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)CompletedNCT00548301Phase 3
- Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye SymptomsCompletedNCT00535054Not applicable
- Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction PhaseCompletedNCT00520260Phase 4
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)CompletedNCT00502073Phase 3
- Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry EyeCompletedNCT00471419Phase 3
- Safety and Efficacy of Optive in Contact Lens Wearers With Dry EyesCompletedNCT00469573Phase 4
- Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye SyndromeCompletedNCT00442273Not applicable
- A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day PeriodCompletedNCT00439400Phase 2
- Effect of B-cell Depletion in Patients With Primary Sjögren's SyndromeCompletedNCT00426543Phase 2
- Goblet Cell Response and Dry Eye Symptoms After PRK and LASIKCompletedNCT00411827Not applicable
- Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With RestasisCompletedNCT00407043Phase 4
- Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye SymptomsCompletedNCT00405457Phase 4
- Study of INS365 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT00404131Phase 3
- Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT00403975Phase 3
- Study of INS365 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT00403715Phase 3
- A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry EyeCompletedNCT00399230Phase 4
- Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye SymptomsCompletedNCT00399061Phase 4
- Comparison of Systane Free vs. Saline in the Treatment of Dry EyeCompletedNCT00388791Phase 4
- Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITE™) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry EyeCompletedNCT00386646Phase 4
- Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye SyndromeCompletedNCT00370747Phase 2
- Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye SyndromeCompletedNCT00357201Phase 2
- A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye DiseaseWithdrawnNCT00355459Not applicable
- Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive KeratectomyCompletedNCT00349440Phase 4
- Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time PointsCompletedNCT00345241Not applicable
- A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye SyndromeCompletedNCT00344721Not applicable
- Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens WearersCompletedNCT00335114Not applicable
- A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a PlaceboCompletedNCT00201981Phase 3
- Study of Rebamipide Eye Drops to Treat Dry EyeCompletedNCT00201955Phase 3
- Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye SyndromeCompletedNCT00198536Phase 2/3
- Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis SiccaCompletedNCT00128245Phase 2
- Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry EyeCompletedNCT00037661Phase 3
- Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye SyndromeCompletedNCT00025818Phase 3
- Treatment of Dry Eye Syndrome With Cyclosporin A Eye DropsCompletedNCT00001731Phase 2